Ecbosure 100 mcg/ml Injection 1 ml belongs to the group of medicines called oxytocic agents indicated for the prevention of uterine atony and postpartum haemorrhage following cesarean section under epidural or spinal anaesthesia. Postpartum haemorrhage is a condition in which excessive bleeding occurs following childbirth

Ecbosure 100 mcg/ml Injection 1 ml contains Carbetocin, which is similar to oxytocin, which is naturally produced by the body and helps the womb contract during childbirth. Ecbosure 100 mcg/ml Injection 1 ml makes the womb contact and reduces the risk of bleeding.

In some cases, Ecbosure 100 mcg/ml Injection 1 ml may cause abdominal pain, dizziness, feeling of warmth, headache, nausea, and vomiting. Most of these side effects may not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, consult a doctor.

Do not receive Ecbosure 100 mcg/ml Injection 1 ml if you are pregnant. Consult the doctor if you are breastfeeding. Ecbosure 100 mcg/ml Injection 1 ml is not recommended for children as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Ecbosure 100 mcg/ml Injection 1 ml is used in the treatment of Postpartum haemorrhage and uterine atony. The detailed uses of Ecbosure 100 mcg/ml Injection 1 ml are as follows:

• Prevent postpartum hemorrhage: Ecbosure 100 mcg/ml Injection 1 ml promotes strong and sustained uterine contractions immediately after childbirth, reducing the risk of excessive bleeding due to uterine atony.
• Support cesarean section recovery: Ecbosure 100 mcg/ml Injection 1 ml is administered after elective cesarean delivery under spinal or epidural anaesthesia to stabilize uterine tone and minimize blood loss.
• Mimic oxytocin activity: Ecbosure 100 mcg/ml Injection 1 ml acts as a long-acting oxytocin receptor agonist, binding to receptors in the uterine muscle to increase contraction frequency and intensity.

• Follow your doctor’s instructions on the dosage and timing of this medication, to improve effectiveness.
• Ecbosure 100 mcg/ml Injection 1 ml will be administered by a healthcare professional.
• Do not self-administer it.

Ecbosure 100 mcg/ml Injection 1 ml belongs to the group of medicines called oxytocic agents indicated for the prevention of uterine atony and postpartum haemorrhage following cesarean section under epidural or spinal anaesthesia. Ecbosure 100 mcg/ml Injection 1 ml contains Carbetocin, which is similar to oxytocin, which is naturally produced by the body and helps the womb contract during childbirth. Ecbosure 100 mcg/ml Injection 1 ml makes the womb contact and reduces the risk of bleeding.

Ecbosure 100 mcg/ml Injection 1 ml should not be used if you are allergic to any of its components, during pregnancy and labour before delivery of the infant, or for the induction of labour. Inform the doctor if you have serious heart disorders, epilepsy, high blood pressure, blood clotting problems, gestational diabetes, migraine, asthma, or liver/kidney impairment. Consult the doctor if you are breastfeeding. The safety and effectiveness of Ecbosure 100 mcg/ml Injection 1 ml in children have not been established. Let your doctor know if you are taking any prescription/non-prescription medicines, including herbal products and supplements.